<?xml version="1.0" encoding="UTF-8"?>
<p>Prevention of the release of the viruses from host cells as the last phase of the viral cycle is an attractive strategy to minimize the dissemination of the virus mainly in pandemics to limit the released viral load in the society. Drugs like zanamivir, oseltamivir, laninamivir octanoate and peramivir inhibit this step by targeting viral neuraminidase to block the release of the Influenza virus (De Clercq &amp; Li, 
 <xref rid="tbed13734-bib-0019" ref-type="ref">2016</xref>). Bone marrow matrix antigen 2 (BST‐2), also known as tetherin or CD 317, was found as the factor causing a defect in virion release of HIV‐1 mutants without the vpu accessory gene (Van Damme et al., 
 <xref rid="tbed13734-bib-0083" ref-type="ref">2008</xref>).
</p>
